Immunosuppressant agents in the treatment of glomerulonephritis. 2. Cytotoxic drugs.
D000328:Adult; D019867:Anti-Glomerular Basement Membrane Disease / Q000188:drug therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D001379:Azathioprine / Q000008:administration & dosage; D002648:Child; D002699:Chlorambucil / Q000008:administration & dosage; D003404:Creatinine / Q000652:urine; D003520:Cyclophosphamide / Q000008:administration & dosage; D004336:Drug Antagonism; D004342:Drug Hypersensitivity; D005921:Glomerulonephritis / Q000188:drug therapy*; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008466:Mechlorethamine / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011507:Proteinuria; D011693:Purpura / Q000188:drug therapy; D012008:Recurrence; D012075:Remission, Spontaneous
D000961:Antilymphocyte Serum; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D008466:Mechlorethamine; D003520:Cyclophosphamide; D011239:Prednisolone; D003404:Creatinine; D001379:Azathioprine